Home » Stocks » AWH

Aspira Women's Health, Inc. (AWH)

Stock Price: $5.98 USD -0.11 (-1.73%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $5.50 -0.48 (-7.95%) Jan 20, 6:06 PM
Market Cap 623.48M
Revenue (ttm) 4.51M
Net Income (ttm) -15.21M
Shares Out 103.20M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $5.98
Previous Close $6.08
Change ($) -0.11
Change (%) -1.73%
Day's Open 6.09
Day's Range 5.74 - 6.24
Day's Volume 604,273
52-Week Range 0.64 - 6.71

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 1 week ago

These winners are positioned for gains even after COVID.

Other stocks mentioned: FLGT, GNMK, NTRA, CODX
GlobeNewsWire - 2 weeks ago

Aspira to participate in the 10 th Annual LifeSci Advisors Corporate Access Event and  Biotech Showcase™ from January 6 – 15 th , 2021

GlobeNewsWire - 4 months ago

AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the ...

GlobeNewsWire - 5 months ago

Conference Call scheduled for today, August 13th at 4:30 p.m. ET Conference Call scheduled for today, August 13th at 4:30 p.m. ET

GlobeNewsWire - 5 months ago

Conference Call scheduled for today, August 13th at 4:30 p.m. ET Conference Call scheduled for today, August 13th at 4:30 p.m. ET

GlobeNewsWire - 5 months ago

AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for...

GlobeNewsWire - 6 months ago

AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“ASPIRA”), a bioanalytical-based women’s health company focused on gynecologic disease, today annou...

Benzinga - 7 months ago

Vermillion, Inc. (NASDAQ: VRML) shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including corona...

GlobeNewsWire - 7 months ago

AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its...

GlobeNewsWire - 7 months ago

AUSTIN, Texas, June 09, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set ...

Seeking Alpha - 8 months ago

Vermillion's (VRML) CEO Valerie Palmieri on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 8 months ago

Conference Call scheduled for today, May 14th at 4:30 p.m. ET Conference Call scheduled for today, May 14th at 4:30 p.m. ET

Seeking Alpha - 9 months ago

Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Vermillion's (VRML) CEO Valerie Palmieri on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Vermillion's (VRML) CEO Valerie Palmieri on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Vermillion, Inc. (VRML) CEO Valerie Palmieri on Q4 2018 Results - Earnings Call Transcript

About AWH

Aspira Women's Health, together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies ... [Read more...]

Industry
Diagnostics & Research
Founded
1993
CEO
Valerie Palmieri
Employees
52
Stock Exchange
NASDAQ
Ticker Symbol
AWH
Full Company Profile

Financial Performance

In 2019, AWH's revenue was $4.54 million, an increase of 48.64% compared to the previous year's $3.05 million. Losses were -$15.24 million, 34.0% more than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for AWH is 8.00, which is an increase of 33.89% from the latest price.

Price Target
$8.00
(33.89% upside)